tm
Seeing Is Believing
tm
Seeing Is Believing
Healthcare - Sector
EBS is currently covered by 4 analysts with an average price target of $16.06. This is a potential upside of $10.18 (173.13%) from yesterday's end of day stock price of $5.88.
Emergent Biosolutions's activity chart (see below) currently has 74 price targets and 73 ratings on display. The stock rating distribution of EBS is 5.88% HOLD, 5.88% SELL and 88.24% BUY.
Analysts average stock forecasts to be materialized ratio is 61.3% with an average time for these price targets to be met of 92.33 days.
Highest price target for EBS is $16, Lowest price target is $12, average price target is $14.33.
Most recent stock forecast was given by RAGHURAM SELVARAJU from HC WAINWRIGHT on 01-Apr-2025. First documented stock forecast 27-Sep-2017.
Currently out of the existing stock ratings of EBS, 1 are a HOLD (5.88%), 1 are a SELL (5.88%), 15 are a BUY (88.24%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$15
$7.83 (109.21%)
$15
4 months ago
(01-Apr-2025)
0/6 (0%)
$10.26 (216.46%)
Buy
$12
$4.83 (67.36%)
$8
8 months 25 days ago
(07-Nov-2024)
7/11 (63.64%)
$1 (9.09%)
23
Buy
$16
$8.83 (123.15%)
$23
10 months 19 days ago
(13-Sep-2024)
10/14 (71.43%)
$8.13 (103.30%)
134
Sell
$9
1 years 8 months 12 days ago
(20-Nov-2023)
2/3 (66.67%)
$0.88 (10.84%)
7
Hold
$15
$7.83 (109.21%)
$29
2 years 2 months 13 days ago
(19-May-2023)
4/8 (50%)
$6.83 (83.60%)
86
What is EBS (Emergent Biosolutions) average time for price targets to be met?
Which analyst has the current highest performing score on EBS (Emergent Biosolutions) with a proven track record?
Which analyst has the current lower performing score on EBS (Emergent Biosolutions) with a proven track record?
Which analyst has the most public recommendations on EBS (Emergent Biosolutions)?
Which analyst is the currently most bullish on EBS (Emergent Biosolutions)?
Which analyst is the currently most reserved on EBS (Emergent Biosolutions)?
